Financial insights of BNBX

MyFinsight

For the year ending 2025-09-30, BNBX made $2,136,935 in revenue. -$69,487,620 in net income. Net profit margin of -3251.74%.

Unit: Dollar

Income Statement	2025-09-30
Total revenues	2,136,935
Cost of product revenues	1,298,028
Gross profit	838,907
Selling, general and administrative	10,868,590
Research and development	6,016,912
Total operating expenses	16,885,502
Loss from operations	-16,046,595
Interest income	192,915
Unrealized gain on change in fair value of warrants classified as a liability	-319,630
Other expense, net	-106,580
Loss before provision for income taxes	-15,640,630
Income tax provision benefit	-684,115
Net loss from continuing operations	-14,956,515
Clinical laboratory service revenues	572,928
Cost of clinical laboratory service revenues	790,455
Gross profit	-217,527
Selling, general and administrative	215,105
Interest (income)	3,301
Other expense, net	36,600
Net loss from discontinued operations	-392,731
Net loss from discontinued operations, net of tax	-392,731
Net loss	-15,349,246
Less net loss attributable to noncontrolling interest	-188,522
Net loss attributable to bnb plus corp	-15,160,724
Deemed dividend related to warrant modifications	54,326,896
Net loss attributable to common stockholders	-69,487,620

Earnings per share, basic	-134.23
Earnings per share, diluted	-134.23
Weighted average number of shares outstanding, basic	517,671
Weighted average number of shares outstanding, diluted	517,671